ABIVAX Société Anonyme (0RA9.L)

EUR 6.51

(0.46%)

Total Debt Summary of ABIVAX Société Anonyme

ABIVAX Société Anonyme's latest annual total debt in 2023 was 55.46 Million EUR , up 18.71% from previous year.
ABIVAX Société Anonyme's latest quarterly total debt in 2024 Q2 was 111.14 Million EUR , down 0.0% from previous quarter.
ABIVAX Société Anonyme reported annual total debt of 46.72 Million EUR in 2022, down -12.58% from previous year.
ABIVAX Société Anonyme reported annual total debt of 53.44 Million EUR in 2021, up 57.28% from previous year.
ABIVAX Société Anonyme reported quarterly total debt of 55.46 Million EUR for 2023 Q4, down 0.0% from previous quarter.
ABIVAX Société Anonyme reported quarterly total debt of 55.46 Million EUR for 2023 FY, up 18.71% from previous quarter.

Annual Total Debt Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Total Debt of ABIVAX Société Anonyme (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	55.46 Million EUR	18.71%
2022	46.72 Million EUR	-12.58%
2021	53.44 Million EUR	57.28%
2020	33.98 Million EUR	63.82%
2019	20.74 Million EUR	90.3%
2018	10.9 Million EUR	4060.31%
2017	262 Thousand EUR	-89.62%
2016	2.52 Million EUR	-26.07%
2015	3.41 Million EUR	63.39%
2014	2.08 Million EUR	-9.95%
2013	2.32 Million EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	111.14 Million EUR	0.0%
2023 Q4	55.46 Million EUR	0.0%
2023 FY	55.46 Million EUR	18.71%
2023 Q2	34.68 Million EUR	0.0%
2022 Q2	49.47 Million EUR	0.0%
2022 Q4	46.72 Million EUR	0.0%
2022 FY	46.72 Million EUR	-12.58%
2021 FY	53.44 Million EUR	57.28%
2021 Q2	31.79 Million EUR	0.0%
2021 Q4	53.44 Million EUR	0.0%
2020 FY	33.98 Million EUR	63.82%
2020 Q2	24.48 Million EUR	0.0%
2020 Q4	33.98 Million EUR	0.0%
2019 Q4	20.74 Million EUR	0.0%
2019 FY	20.74 Million EUR	90.3%
2019 Q2	21.8 Million EUR	0.0%
2018 Q2	- EUR	0.0%
2018 FY	10.9 Million EUR	4060.31%
2018 Q4	10.9 Million EUR	0.0%
2017 Q4	262 Thousand EUR	0.0%
2017 FY	262 Thousand EUR	-89.62%
2017 Q2	331 Thousand EUR	0.0%
2016 Q4	316 Thousand EUR	0.0%
2016 Q2	386 Thousand EUR	0.0%
2016 FY	2.52 Million EUR	-26.07%
2015 Q4	405 Thousand EUR	0.0%
2015 FY	3.41 Million EUR	63.39%
2015 Q2	574 Thousand EUR	0.0%
2014 Q4	2.08 Million EUR	0.0%
2014 Q3	- EUR	0.0%
2014 FY	2.08 Million EUR	-9.95%
2014 Q1	- EUR	0.0%
2013 FY	2.32 Million EUR	0.0%

Peer Total Debt Comparison of ABIVAX Société Anonyme

Name	Total Debt	Total Debt Difference
Boiron SA	13.7 Million EUR	-304.788%
Laboratorios Farmaceuticos Rovi, S.A.	46.63 Million EUR	-18.932%
Vetoquinol SA	17.62 Million EUR	-214.636%
Valneva SE	208.81 Million EUR	73.439%
AB Science S.A.	19.1 Million EUR	-190.372%
Nanobiotix S.A.	45.48 Million EUR	-21.944%
PHAXIAM Therapeutics S.A.	10.19 Million EUR	-443.818%
Vivoryon Therapeutics N.V.	38 Thousand EUR	-145857.895%
BioSenic S.A.	28.16 Million EUR	-96.953%
Formycon AG	29.48 Million EUR	-88.103%